Security key
140755109
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)
CUSIP: 140755109
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 24,377,112
- Total 13F value
- $18,109,185
- Share change
- -3,050,908
- Put/Call ratio
- 20%
- SEC-reported price per share
- $0.74
- Number of holders
- 107
- Value change
- -$5,083,037
- Number of buys
- 42
- Number of sells
- 60
- Shares outstanding
- 54,790,889
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
107
Top holders
10
CARA full security history
Ownership snapshot
Full 13F holder table
Tvardi Therapeutics, Inc. SEC filings
Tvardi Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CSL LTD
Disclosed value leader
CSL LTD
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5
13F
Highest disclosed value: $9,024,059
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
CSL LTD has the largest disclosed position value at $9.02M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CSL LTD's linked filing trail.
Disclosed position value
Top 5
CSL LTD
$9.02M
Vifor (International) Ltd
$9.02M
BlackRock Finance, Inc.
$6.23M
VANGUARD GROUP INC
$4.37M
DISCIPLINED GROWTH INVESTORS INC /MN
$2.98M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CSL LTD |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$9,024,059
7,396,770 shares
|
— | 09 Aug 2022 |
| Vifor (International) Ltd |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$9,024,059
7,396,770 shares
|
— | 20 Oct 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$6,229,610
3,708,101 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$4,365,394
2,598,449 shares
|
— | 30 Sep 2023 |
| DISCIPLINED GROWTH INVESTORS INC /MN |
13F
Company
|
—
denominator unverified
|
$2,977,627
1,772,397 shares
|
— | 30 Sep 2023 |
| Chescapmanager LLC |
13F
Company
|
—
denominator unverified
|
$2,951,142
1,756,632 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
107
Shares
24,377,112
Rows available
107
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
121
Q4 2023 holders
107
Holder diff
-14
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|